II. Indications
- Urinary Tract Infection
- Pneumocystis carinii prophylaxis and treatment
III. Contraindications
- Avoid in infant under age 2 months
- Sulfonamide Allergy
IV. Adverse Effects: General
- Allergic Reaction or Anaphylaxis
- Bone Marrow suppression (Agranulocytosis)
- Steven's Johnson Syndrome
- Toxic Epidermal Necrolysis
-
Hyperkalemia
- Related to trimethoprim component
- Higher risk with underlying Renal Insufficiency
- Exacerbated by ACE Inhibitor, Angiotensin Receptor Blocker, and Potassium supplements
V. Adverse Effects: HIV patients (40-60% within 3 weeks)
- Hepatitis
- Neutropenia
- Anemia
- Hyponatremia
- Hyperkalemia (6% of patients, esp. elderly)
- Nausea or Vomiting
- Rash
- Fever
VI. Drug Interactions
- Other drugs decrease Trimethoprim Sulfamethoxazole levels
- Trimethoprim Sulfamethoxazole increases other drug levels
-
Hyperkalemia risk
- Increased risk with ACE Inhibitors, Angiotensin Receptor Blockers, Spironolactone
- Higher risk with age >65 years, Renal Insufficiency, Diabetes Mellitus and Heart Failure
- Significantly increased rate of hospitalization and sudden death
- Avoid Septra use for longer than three days with these agents and comorbidities in age >65 years
- Consider alternative antibiotics, holding antihypertensive or recheck Serum Potassium in 4-5 days
- Fralick (2014) BMJ 349:g6196 +PMID:25359996 [PubMed]
- References
- Tarascon Pharmacopoeia, accessed online 8/8/2014
- (2014) Presc lett 21(8): 47
VII. Precautions
- Prolonged use may cause very severe adverse reactions
- Follow CBC in prolonged use
- Hyperkalemia risk (especially in Renal Insufficiency)
VIII. Preparations
- Double Strength (DS)
- Trimethoprim 160 mg
- Sulfamethoxazole 800 mg
- Single Strength (SS)
- Trimethoprim 80 mg
- Sulfamethoxazole 400 mg
- Pediatric Suspension (40/200 per 5 ml)
- Trimethoprim 40 mg per 5 ml
- Sulfamethoxazole 200 mg per 5 ml
IX. Dosing: Directions (regarding Sulfonamide component)
- Take on an empty Stomach
- Take more than 1 hour before or two hours after food
X. Dosing: Children (Using 40/200 per 5 ml suspension)
- Treatment
- Dose 8 mg/kg/day of TMP component PO divided bid
- For each 10 kg weight, dose 5 ml suspension bid (up to maximum of 20 ml/dose)
- Examples
- Age 2 months (5 kg): 2.5 ml orally twice daily
- Age 1 year (10 kg): 5.0 ml orally twice daily
- Age 3 years (15 kg): 7.5 ml orally twice daily
- Age 5 years (20 kg): 10 ml orally twice daily
- Prophylaxis of Urinary Tract Infections
- Dose: 4 mg/kg/day of Trimethoprim dosed once daily
- Avoid use with marked Hyperbilirubinemia
XI. Dosing: Adults
- Standard: 1 DS tablet orally twice daily
- Cellulitis: 1-2 DS tablet orally twice daily
XII. Dosing: Renal Insufficiency
-
Creatinine Clearance: 15-30 ml/min
- Decrease Trimethoprim-Sulfamethoxazole dose by 50%
-
Creatinine Clearance: <15 ml/min
- Avoid the use of Trimethoprim Sulfamethoxazole
- References
- Tarascon Pharmacopoeia, accessed online 8/8/2014
XIII. Dosing: HIV
- Pneumocystis: PO or IV (15 mg/kg of trimethoprim/day)
Images: Related links to external sites (from Bing)
Related Studies
sulfatrim (on 12/21/2022 at Medicaid.Gov Survey of pharmacy drug pricing) | ||
SULFATRIM PEDIATRIC SUSPENSION | Generic | $0.06 per ml |